Universitätsklinikum Würzburg

Hospital


Location: Würzburg, Germany (DE) DE

ISNI: 0000000113787891

ROR: https://ror.org/03pvr2g57

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Prospective Clinical Phase II Results on Treosulfan-Based Conditioning Treatment of 70 Paediatric Patients with Haematological Malignancies (2018) Kalwak K, Bader P, Styczynski J, Gruhn B, Patrick K, Sedlacek P, Stachel D, et al. Conference contribution Nuclear calcineurin is a sensor for detecting Ca2+ release from the nuclear envelope via IP3R (2018) Olivares-Florez S, Czolbe M, Riediger F, Seidlmayer L, Williams T, Nordbeck P, Strasen J, et al. Journal article Modulation of sustained fear by transcranial direct current stimulation (tDCS) of the right inferior frontal cortex (rIFC) (2018) Herrmann MJ, Simons BSE, Horst AK, Böhme S, Straube T, Polak T Journal article European myeloma network recommendations on tools for the diagnosis and monitoring of multiple myeloma: What to use and when (2018) Caers J, Garderet L, Kortuem KM, O'Dwyer ME, Van De Donk NWCJ, Binder M, Dold SM, et al. Journal article Neutrophils promote atherosclerotic plaque destabilization in amousemodel of endotoxinaemia (2018) Cochain C, Ait-Oufella H, Zernecke A Journal article Non-viral therapeutic cell engineering with the Sleeping Beauty transposon system (2018) Hudecek M, Ivics Z Journal article, Review article Real-world effectiveness of ribociclib 1 aromatase inhibitor, or endocrine monotherapy, or chemotherapy as first-line treatment in postmenopausal women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: The RIBANNA study (2018) Fasching P, Decker T, Guderian G, Heim J, Jackisch C, Lueck HJ, Lueftner D, et al. Conference contribution Phase I study of the heparanase inhibitor roneparstat: An innovative approach for multiple myeloma therapy (2018) Galli M, Chatterjee M, Grasso M, Specchia G, Magen H, Einsele H, Celeghini I, et al. Journal article LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy (2018) Rossow L, Veitl S, Vorlova S, Wax JK, Kuhn AE, Maltzahn V, Upcin B, et al. Journal article Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation (2018) Stolzenburg A, Lueckerath K, Samnick S, Speer M, Kneer K, Schmid JS, Grigoleit GU, et al. Journal article